Drugs / Saccharomyces Cerevisiae CNCM I-3856
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT00977587 Comparator | Jan 2011 → Jan 2012 | irritable bowel syndrome, post-infectious syndrome | University of Nottingham | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Saccharomyces Cerevisiae CNCM I-3856 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00977587 ↗ |
| Route | Oral | “subjects will take 1 capsule twice a day” NCT00977587 ↗ |